Atlas Trials

Safety and Efficacy Study of HER2/Neu (E75) Vaccine in Node-Positive Breast Cancer Patients

Clinical trial NCT00841399 · COMPLETED

Trial details

NCT number
NCT00841399
Sponsor
COL George Peoples, MD, FACS
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Breast Cancer
Start date
2001-07-01
Primary completion
2012-09-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.